Editas Medicine Inc

25 de set. de 2026, 20:08 UTC

Prime Medicine Inc shares fell sharply despite FDA clearance for its gene-editing therapy, contributing to a broader market downturn and a significant cumulative decline since Thursday.

24 de set. de 2026, 20:14 UTC

Editas Medicine Inc is trading higher in after-market hours, potentially influenced by Prime Medicine Inc's FDA clearance for its Investigational New Drug application.

23 de set. de 2026, 22:01 UTC

Editas Medicine Inc is advancing in after-market trading, reflecting a notable increase since Wednesday's close after being below its 20-day moving average.

22 de set. de 2026, 19:45 UTC

Editas Medicine Inc is trading higher, benefiting from strength in biotechnology stocks, despite remaining below its 20-day moving average.

21 de set. de 2026, 21:51 UTC

Editas Medicine Inc is trading higher in after-market hours, recovering from significant volatility, but remains 2.00% below its 20-day moving average.

18 de set. de 2026, 21:51 UTC

Editas Medicine Inc is advancing in after-market trading, moving higher alongside the broader market amid macroeconomic concerns and geopolitical tensions.

17 de set. de 2026, 23:01 UTC

Editas Medicine Inc is higher in after-market trading, recovering from earlier lows, though it remains below its 20-day moving average.

16 de set. de 2026, 20:07 UTC

Editas Medicine Inc is gaining in Wednesday's session, reflecting a positive trend since Tuesday's close, despite remaining below its 20-day moving average.

15 de set. de 2026, 23:51 UTC

Editas Medicine Inc shares are higher in after-market trading. No specific company news was identified to explain this price movement.

10 de set. de 2026, 20:08 UTC

Editas Medicine Inc shares are lower, extending a three-day decline amid broader biotechnology sector weakness and pressures from the European Central Bank's recent interest rate hike.

9 de set. de 2026, 22:11 UTC

Editas Medicine Inc shares are higher in after-market trading, reflecting a notable increase since Wednesday's close, despite being below its 20-day moving average.

8 de set. de 2026, 20:08 UTC

Editas Medicine appoints Dan Ory as Chief Medical Officer, shares decline sharply amid market response. The stock has reached a session low today.

4 de set. de 2026, 23:02 UTC

Editas Medicine Inc shares are lower during after-market hours, reflecting a decline despite being above its 20-day moving average and near one-month highs.

1 de set. de 2026, 19:16 UTC

Editas Medicine is participating in two investor conferences, enhancing visibility. Shares are higher today, reflecting positive investor interest in its CRISPR technology focus.

31 de ago. de 2026, 22:51 UTC

Editas Medicine has filed a prospectus for a $400 million mixed securities shelf offering, contributing to higher shares during after-market hours.

28 de ago. de 2026, 20:03 UTC

Editas Medicine Inc shares are lower today, retracing from earlier highs. Broader market dynamics, including rising Treasury yields, may be contributing to the decline.

27 de ago. de 2026, 23:02 UTC

Editas Medicine Inc is trading higher in after-market hours, reflecting positive sentiment since Thursday's close and resilience despite earlier session pullbacks.

26 de ago. de 2026, 23:16 UTC

Editas Medicine Inc shares are higher in after-market trading, positioned near the upper end of their one-month range and above the 20-day moving average.

25 de ago. de 2026, 19:21 UTC

Editas Medicine Inc is seeing gains during Tuesday's session, reaching a peak return earlier before pulling back slightly. Broader market sentiment remains favorable for biotech stocks.

24 de ago. de 2026, 22:22 UTC

Editas Medicine Inc shares are higher in after-market trading, showing some volatility. No specific news was identified to explain the price movement.

21 de ago. de 2026, 23:16 UTC

Editas Medicine Inc shares are lower in after-market trading. No specific news was identified to explain the decline, though the stock remains above its 20-day moving average.

20 de ago. de 2026, 23:46 UTC

Editas Medicine Inc is higher in after-market hours, gaining since Thursday's close. The stock is above its 20-day moving average amid no specific news.

19 de ago. de 2026, 23:21 UTC

Editas Medicine Inc. shares are lower in after-market hours, impacted by a decline in the Biotechnology sub-sector. No specific news was identified for the movement.

17 de ago. de 2026, 19:16 UTC

Editas Medicine Inc. shares are trading roughly flat amid overall market sentiment influenced by recent declines in U.S. retail sales and consumer sentiment.

14 de ago. de 2026, 22:21 UTC

Editas Medicine Inc is trading lower in after-market hours, continuing a decline over the past four sessions amid broader concerns over consumer demand.

13 de ago. de 2026, 21:32 UTC

Editas Medicine Inc advanced in after-hours trading, reflecting a shift in investor sentiment and aligning with a positive trend in the biotechnology sector.

12 de ago. de 2026, 19:31 UTC

Editas Medicine Inc shares are lower today, continuing a decline since Tuesday. No specific news has been identified to explain the drop.

11 de ago. de 2026, 19:46 UTC

Editas Medicine Inc shares are trading higher today, reflecting unusual strength. No specific company news was identified to explain this price action.

10 de ago. de 2026, 23:26 UTC

Editas Medicine Inc shares are higher in after-market hours. No specific company news was identified to explain this movement amid broader market uncertainties.

7 de ago. de 2026, 23:16 UTC

Editas Medicine Inc. shares were little changed in after-market trading, with no specific news identified. The stock remains above its 20-day moving average.